23andMe and Nightingale Well being will collectively supply a blood-based danger evaluation pilot venture
What it’s essential know:
– 23andMe Holding Co., a number one participant in preventive healthcare and therapeutics, and Nightingale Well being, a pioneer in biomarker testing, introduced a collaboration to check Nightingale's blood metabolomics panel with a bunch of 23andMe members.
– This pilot program represents an necessary step ahead in customized well being evaluation. By combining genetic and blood biomarker knowledge, 23andMe and Nightingale Well being are paving the best way for a future the place people can take a extra proactive method to managing their well being and wellness.
Unlocking deeper well being insights
This pilot program provides a glimpse into the way forward for customized well being assessments. That is what it entails:
- Nightingale's Distant Well being Test: This revolutionary blood check measures dozens of biomarkers, together with ldl cholesterol, apolipoproteins and fatty acids. These markers can present useful insights into illness danger and assist customized well being methods.
- Improved danger prediction: Nightingale’s blood panel knowledge can be built-in with 23andMe’s current genetic assessments. This mixed method has the potential to enhance the accuracy of danger assessments for quite a lot of well being situations.
- Actionable insights: By combining genetic and blood biomarker knowledge, 23andMe goals to supply customers with extra actionable insights. This will help people determine areas for enchancment, reminiscent of food plan or train changes, to optimize their well being.
A pilot program for customized well being
As a part of this initiative, 23andMe will supply as much as 5,000 of its premium and whole well being members the chance to obtain Nightingale’s Distant Well being Test blood check for gratis. This pilot program will serve a number of functions:
- Acquire person suggestions: 23andMe is gathering suggestions from members about their experiences with blood testing, residence pattern assortment, and the worth of mixing genetic and blood biomarker knowledge.
- Evaluating Information Integration: The pilot will look at the extent to which 23andMe can successfully combine Nightingale's blood check knowledge with its current genetic testing platform.
“This partnership permits a globally distinctive characteristic set for 23andMe's shopper well being providers. Collectively we will help clients observe and enhance their well being with common blood assessments utilizing Nightingale Well being's expertise,” mentioned Teemu Suna, CEO and Founding father of Nightingale Well being . “This marks an necessary step within the execution of Nightingale Well being's technique because it publicizes a serious partnership offering entry to the buyer well being market.”